We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$82.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
1 quarter
Avg Time Held Equity only
4.4 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
1 quarter

Top Buys

Rank Stock Value
1
JNPR icon
Juniper Networks
JNPR
+$162M
2
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS icon
Ansys
ANSS
+$119M
4
X icon
US Steel
X
+$104M
5
CTLT icon
CATALENT, INC.
CTLT
+$93.3M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Miscellaneous 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CONXW icon
426
DELISTED
CONX Corp. Warrant
CONXW
$55.5K ﹤0.01%
316,890
– –
2021 Q1
12 quarters
MRUS icon
427
CALL
DELISTED
Merus
MRUS
$53K ﹤0.01%
+20,000
New +$811K
2024 Q1
0 quarters
NVO icon
428
CALL
Novo Nordisk
NVO
$171B
$51.8K ﹤0.01%
+45,000
New +$5.36M
2024 Q1
0 quarters
HOG icon
429
PUT
Harley-Davidson
HOG
$2.8B
$50K ﹤0.01%
100,000
-150,000
-60% -$5.55M
2023 Q3
2 quarters
MRUS icon
430
PUT
DELISTED
Merus
MRUS
$50K ﹤0.01%
+20,000
New +$811K
2024 Q1
0 quarters
ORIC icon
431
CALL
Oric Pharmaceuticals
ORIC
$1.24B
$50K ﹤0.01%
+80,000
New +$950K
2024 Q1
0 quarters
SNDX icon
432
CALL
Syndax Pharmaceuticals
SNDX
$1.52B
$44.9K ﹤0.01%
77,400
+2,400
+3% +$53.5K
2023 Q3
2 quarters
PTCT icon
433
CALL
PTC Therapeutics
PTCT
$5.4B
$44.5K ﹤0.01%
20,000
-30,000
-60% -$840K
2023 Q4
1 quarter
HLT icon
434
PUT
Hilton Worldwide
HLT
$73.5B
$44.2K ﹤0.01%
15,500
+1,500
+11% +$295K
2022 Q1
8 quarters
AM icon
435
PUT
Antero Midstream
AM
$10B
$43.1K ﹤0.01%
+95,800
New +$1.23M
2024 Q1
0 quarters
CVIIW icon
436
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$42.7K ﹤0.01%
133,530
– –
2021 Q2
11 quarters
XIFR icon
437
PUT
XPLR Infrastructure LP
XIFR
$978M
$39.3K ﹤0.01%
27,100
-62,900
-70% -$1.79M
2023 Q3
2 quarters
JWSM.WS icon
438
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$38.8K ﹤0.01%
172,581
– –
2021 Q2
11 quarters
TREE icon
439
PUT
LendingTree
TREE
$354M
$38.8K ﹤0.01%
+50,000
New +$1.75M
2024 Q1
0 quarters
OFIX icon
440
CALL
Orthofix Medical
OFIX
$374M
$37.5K ﹤0.01%
+50,000
New +$691K
2024 Q1
0 quarters
KPTI icon
441
CALL
Karyopharm Therapeutics
KPTI
$13.7M
$33.9K ﹤0.01%
21,720
+1,720
+9% +$30.2K
2023 Q3
2 quarters
BIIB icon
442
CALL
Biogen
BIIB
$33.3B
$33.3K ﹤0.01%
18,000
+8,000
+80% +$1.87M
2023 Q4
1 quarter
DNLI icon
443
CALL
Denali Therapeutics
DNLI
$3.11B
$30K ﹤0.01%
+50,000
New +$940K
2024 Q1
0 quarters
MIRM icon
444
CALL
Mirum Pharmaceuticals
MIRM
$5.58B
$26.9K ﹤0.01%
+25,000
New +$687K
2024 Q1
0 quarters
VST icon
445
PUT
Vistra
VST
$54.2B
$26.5K ﹤0.01%
+27,900
New +$1.38M
2024 Q1
0 quarters
RDN icon
446
PUT
Radian Group
RDN
$4.49B
$22.8K ﹤0.01%
59,000
+9,000
+18% +$265K
2021 Q2
11 quarters
BSLKW
447
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$20.1K ﹤0.01%
114,498
– –
2022 Q1
8 quarters
IOVA icon
448
CALL
Iovance Biotherapeutics
IOVA
$6.62B
$20K ﹤0.01%
40,000
-290,000
-88% -$3.38M
2023 Q3
2 quarters
BNAIW icon
449
Brand Engagement Network Warrant
BNAIW
$888K
$19.8K ﹤0.01%
+153,567
New +$16K
2024 Q1
0 quarters
LEGN icon
450
CALL
Legend Biotech
LEGN
$3.62B
$18.5K ﹤0.01%
30,000
+17,500
+140% +$1.06M
2023 Q4
1 quarter

Similar funds

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.